Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

Realm Therapeutics plc - Leading Independent Proxy Advisory Firm ISS Recommends Voting for Proposed Acquisition by Essa Pharma.

Document Cited authorities 1 Cited in Related
Vincent

ENPNewswire-June 12, 2019--Realm Therapeutics plc - Leading Independent Proxy Advisory Firm ISS Recommends Voting for Proposed Acquisition by Essa Pharma

(C)2019 ENPublishing - http://www.enpublishing.co.uk

Release date- 11062019 - Malvern - Realm Therapeutics plc ('Realm' or the 'Company') (NASDAQ: RLM) today announces that Institutional Shareholder Services ('ISS'), a leading independent proxy advisory firm, has recommended that Realm shareholders vote for and approve the proposed acquisition of Realm by Essa Pharma Inc. ('Essa') (NASDAQ: EPIX; TSX-V: EPI) (the 'Acquisition').

The Acquisition, which is to be effected by means of a Court-sanctioned scheme of arrangement under Part 26 of the UK Companies Act 2006, is subject to the terms and conditions set out in the scheme document published on 29 May 2019 and available on the Company's website (www.realmtx.com) (the 'Scheme Document'). Unless otherwise defined herein, capitalized terms and expressions used in this announcement shall have the meanings given to them in the Scheme Document.

On June 24 2019, Realm will hold a Court Meeting, a General Meeting and an Annual General Meeting to vote on the proposed Acquisition and other matters. ISS has recommended that Realm shareholders vote in favor of the Scheme at the Court Meeting and in favor of the Resolution at the General Meeting. At the Annual General Meeting, the Company has proposed ten (10) resolutions, nine (9) of...

To continue reading

Request your trial
COPYRIGHT Normans Media Ltd.

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT